Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 18, 2006, 10.1148/radiol.2393041382
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2393041382v1
239/3/740    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, E. E.
Right arrow Articles by Lee, T.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, E. E.
Right arrow Articles by Lee, T.-Y.
(Radiology 2006;239:740-750.)
© RSNA, 2006


Experimental Studies

Correlation between Hepatic Tumor Blood Flow and Glucose Utilization in a Rabbit Liver Tumor Model1

Errol E. Stewart, HBSc, Xaiogang Chen, PhD, Jennifer Hadway, RVT and Ting-Yim Lee, PhD, FCCPM

1 From the Lawson Health Research Institute, St Joseph's Health Care London, London, Ontario, Canada (E.E.S., J.H., T.Y.L.); Department of Medical Biophysics, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada (E.E.S., T.Y.L.); and Imaging Research Laboratories, Robarts Research Institute, 100 Perth Dr, London, ON, Canada N6A 5K8 (E.E.S., X.C., J.H., T.Y.L.). Received August 10, 2004; revision requested October 19; final revision received July 6, 2005; final version accepted August 1. Supported by the Canadian Institutes of Health Research. E.E.S. supported in part by GE Healthcare. Address correspondence to T.Y.L. (e-mail: tlee{at}imaging.robarts.ca).

Purpose: To prospectively determine the relationship between hepatic tumor blood flow and glucose utilization in vivo by using a combined positron emission tomographic (PET)/computed tomographic (CT) scanner.

Materials and Methods: The animal care and use subcommittee at the University of Western Ontario approved this study. VX2 carcinoma cells were implanted in the livers of eight male New Zealand white rabbits. Functional CT was performed before tumor implantation and every 4 days thereafter. Each examination consisted of two phases: In the first phase, 30-second cine breath-hold scanning was performed with simultaneous injection of 5 mL of contrast material. In the second phase, 4-second cine scanning was performed without breath holding every 10 seconds for 2 minutes. Second-phase CT images were coregistered with first-phase images to eliminate breathing artifacts. The weighted summation of the aortic and portal venous time-attenuation curves was deconvolved against curves from the liver to derive hepatic blood flow (HBF). Five animals underwent fluorine 18 fluorodeoxyglucose (FDG) scanning before and every 8 days after implantation. FDG uptake was measured as standardized uptake value (SUV). Data were analyzed with repeated-measures analysis of variance and the Tukey-Kramer multiple comparison test. Linear regression was used to compare SUV and HBF in tumors and normal tissue.

Results: In the hypovascular tumor core, (a) mean HBF decreased from 262 mL · min–1 · 100 g–1 ± 22 (standard deviation) at baseline to 101 mL · min–1 · 100 g–1 ± 62 at the end of the study (P < .05) and (b) mean SUV increased from 2.12 g/mL ± 0.06 to 4.56 g/mL ± 0.73 (P < .05) during the same period.

Conclusion: Functional CT in combination with FDG PET can be used to observe changes in HBF and glucose utilization in a growing liver tumor.

© RSNA, 2006




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
S. Bisdas, K. Spicer, and Z. Rumboldt
Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging
AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1376 - 1381.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
V. Goh, S. Halligan, A. Gharpuray, D. Wellsted, J. Sundin, and C. I. Bartram
Quantitative Assessment of Colorectal Cancer Tumor Vascular Parameters by Using Perfusion CT: Influence of Tumor Region of Interest
Radiology, June 1, 2008; 247(3): 726 - 732.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
Y-x He and Q-y Guo
Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms
Postgrad. Med. J., May 1, 2008; 84(991): 246 - 251.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. van den Hoff, T.-Y. Lee, and E. Stewart
Blood Flow Quantification with Permeable Contrast Agents: A Valid Technique?
Radiology, June 1, 2007; 243(3): 909 - 910.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2006 by the Radiological Society of North America.